×

Biomolecular contrast agents for therapy optimization in radiation therapy with proton or ion beams

  • US 20050259779A1
  • Filed: 05/18/2004
  • Published: 11/24/2005
  • Est. Priority Date: 05/18/2004
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for treating a target with a beam of energy, said target being within a biological organism, said method comprising:

  • introducing a bio-molecular contrast agent (BMCA) into said biological organism, said BMCA being capable of at least one of binding to said target and reacting with said target, said BMCA capable of also giving detectable signals;

    irradiating said target using said beam of energy in accordance with a pre-therapy plan;

    after said BMCA has bound or reacted to said target, determining if said BMCA signals indicate that the conditions of said target have varied from said pre-therapy plan;

    if deemed necessary optimizing said irradiating of said target in accordance with varied conditions.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×